Home Alcresta

Alcresta

acquired
Series B
Biotechnology Research Merchant
Basic
Enterprise Profile

Basic Information

Alcresta Therapeutics, Inc. is a biotechnology company developing enzyme-based products designed to combat gastrointestinal diseases. The company's digestive enzyme cartridge is designed to mimic the function of pancreatic lipase, enabling patients and the medical community to effectively address acute or chronic conditions caused by pancreatic insufficiency or fat malabsorption.
Alcresta Therapeutics, Inc.
Massachusetts,United States of America
less than 15 people
January 01, 2011
info@alcresta.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Medical Consumables Manufacturing
Technology
Biotechnology Enzymatic Process
Concept
Rare Diseases Chronic Disease Therapeutic Products Pancreatic Cancer Irritable Bowel Syndrome
Application Scenarios
Medical Device Consumables